Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression

Neurogranin (Ng) is a dendritic protein associated with synaptic plasticity, proposed to be a novel biomarker to measure synaptic dysfunction and degeneration in Alzheimer’s disease. Since electroconvulsive therapy (ECT) has been suggested to facilitate neurogenesis and neural plasticity, we tested...

Full description

Saved in:
Bibliographic Details
Main Authors: Kranaster, Laura (Author) , Sartorius, Alexander (Author)
Format: Article (Journal)
Language:English
Published: December 2017
In: Journal of neural transmission
Year: 2017, Volume: 124, Issue: 12, Pages: 1641-1645
ISSN:1435-1463
DOI:10.1007/s00702-017-1802-z
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00702-017-1802-z
Verlag, Volltext: http://link.springer.com/article/10.1007/s00702-017-1802-z
Get full text
Author Notes:Laura Kranaster, Kaj Blennow, Henrik Zetterberg, Alexander Sartorius
Description
Summary:Neurogranin (Ng) is a dendritic protein associated with synaptic plasticity, proposed to be a novel biomarker to measure synaptic dysfunction and degeneration in Alzheimer’s disease. Since electroconvulsive therapy (ECT) has been suggested to facilitate neurogenesis and neural plasticity, we tested whether ECT could modify CSF Ng concentrations measured before and after a course of ECT in 12 patients with major depression. CSF Ng concentrations did not change, but baseline levels were positively correlated with the therapeutic response.
Item Description:First online: 23 October 2017
Gesehen am 06.06.2018
Physical Description:Online Resource
ISSN:1435-1463
DOI:10.1007/s00702-017-1802-z